LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Option Care Health Inc

Închisă

SectorSănătate

35.42 3

Rezumat

Modificarea prețului

24h

Curent

Minim

35.19

Maxim

35.44

Indicatori cheie

By Trading Economics

Venit

1.3M

52M

Vânzări

19M

1.4B

P/E

Medie Sector

26.325

121.746

Marjă de profit

3.611

Angajați

8,000

EBITDA

53M

156M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+9.29% upside

Dividende

By Dow Jones

Următoarele câștiguri

24 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

854M

5.4B

Deschiderea anterioară

32.42

Închiderea anterioară

35.42

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Option Care Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 feb. 2026, 23:21 UTC

Achiziții, Fuziuni, Preluări

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 feb. 2026, 23:45 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 feb. 2026, 23:40 UTC

Market Talk

Gold Falls on Possible Position Adjustments -- Market Talk

15 feb. 2026, 23:06 UTC

Câștiguri

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 feb. 2026, 23:04 UTC

Câștiguri

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 feb. 2026, 23:04 UTC

Câștiguri

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 feb. 2026, 23:01 UTC

Câștiguri

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 feb. 2026, 23:01 UTC

Câștiguri

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 feb. 2026, 22:58 UTC

Câștiguri

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 feb. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 feb. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 feb. 2026, 22:52 UTC

Achiziții, Fuziuni, Preluări

Qube Shareholders to Receive A$5.20/Share in Cash

15 feb. 2026, 22:52 UTC

Achiziții, Fuziuni, Preluări

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 feb. 2026, 21:35 UTC

Câștiguri

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 feb. 2026, 20:48 UTC

Câștiguri

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 feb. 2026, 20:47 UTC

Câștiguri

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 feb. 2026, 20:46 UTC

Câștiguri

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 feb. 2026, 20:45 UTC

Câștiguri

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 feb. 2026, 20:44 UTC

Câștiguri

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 feb. 2026, 20:44 UTC

Câștiguri

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 feb. 2026, 20:43 UTC

Câștiguri

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 feb. 2026, 20:42 UTC

Câștiguri

BlueScope Net Debt A$2.2 Million at Dec. 31

15 feb. 2026, 20:42 UTC

Câștiguri

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 feb. 2026, 20:41 UTC

Câștiguri

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 feb. 2026, 20:40 UTC

Câștiguri

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 feb. 2026, 20:40 UTC

Câștiguri

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 feb. 2026, 20:39 UTC

Câștiguri

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

15 feb. 2026, 20:38 UTC

Câștiguri

BlueScope Targeting A$1.30/Share Annual Ordinary Dividend

15 feb. 2026, 20:37 UTC

Câștiguri

BlueScope Targeting Shareholder Returns of A$3.00/Share in 2026

15 feb. 2026, 20:37 UTC

Câștiguri

BlueScope Interim Dividend 65 Australian Cents/Share

Comparație

Modificare preț

Option Care Health Inc Așteptări

Obiectiv de preț

By TipRanks

9.29% sus

Prognoză pe 12 luni

Medie 38.71 USD  9.29%

Maxim 42 USD

Minim 36 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOption Care Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

9 ratings

8

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

31.11 / 32.41Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Neutral Evidence

Termen lung

Strong Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
help-icon Live chat